🔗 Share this article Social Media Content Creators Fueling Parallel Trade for Unlicensed Slimming Drug A shadow market for unapproved slimming drugs is propelled by TikTok fitness influencers and sellers on communication apps, according to recent findings. Investigational Drug Gaining Traction Via Social Media The experimental drug, which remains in clinical trials, is being promoted by online personalities for its supposed weight-reducing properties. Viewers are urged to message these profiles directly for supplier links, while also obtaining promotional offers. Active Trade on Messaging Platforms Separately, a flourishing market exists on Telegram, where communities with thousands of members share comparison images, administration instructions and claims of rapid UK delivery. Vendors promote the substance there before directing customers to WhatsApp for purchases. Learning About The Experimental Drug Retatrutide is an experimental injectable created by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could assist individuals lose up to a quarter of their body weight. Referred to as the “triple G”, the drug is being hailed online as the successor to Ozempic. Healthcare Professionals Express Concerns Nevertheless, doctors and chemists have warned that the sale of what remains an unlicensed drug in the UK is worrisome and could lead to individuals injecting products of unknown origin. Several experts said the demand for retatrutide could be linked to the increasing price of licensed weight loss treatments such as Mounjaro. Legal Position and Enforcement Marketing retatrutide on TikTok or messaging apps is prohibited in the UK, as it is an unlicensed drug that cannot be marketed or supplied for personal consumption under the British medical regulations. Some content creators try to circumvent the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and supply can still violate medicines, advertising, and customer regulations, risking fines, legal action or prison. Platform Response and Material Elimination Based on the social media company, the platform has taken down problematic material and banned related keywords and search suggestions. The organization stated it was dedicated to maintaining the service safe and allocating resources in strengthening enforcement strategies. Online Trading Activities Research also discovered communities with up to 9,000 participants selling the experimental drug using the platform's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” instantly displays groups with thousands of members, populated with images of slimming results, positive reviews and step-by-step instructions for preparing or injecting at home. Within moments of entering one group, a seller posted WhatsApp details, where most transactions take place. The vendor sent an instruction manual and guaranteed delivery within 48 hours. When questioned whether the product was authentic, one vendor said: “You can’t be sure.” Another provided a image of a alleged testing documentation. Not one asked about weight, medical conditions or past usage. Product Information and Costs Within these groups, posts display dark colored packages with postal service stickers, stating to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.” Buyers can choose between dry substance containers, mixed at residence with purified liquid, or pre-filled injectors typically sold at 160 pounds for 20mg. When questioned how much time a pen should last, sellers give conflicting responses varying between a few weeks to “depends on your body”. Service Oversight and Security Actions A spokesperson for Telegram stated it regularly moderated harmful material on its platform including material that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”. Healthcare Expert Warnings “Individuals are administering materials they can’t verify. Even if the research behind retatrutide is sound, these online products may not include what they advertise,” stated a pharmacy expert, the director of pharmaceutical services at a pharmacy service. Dr Crystal Wyllie of Asda Online Doctor connected the increase in interest to recent cost increases for authorized slimming drugs such as Mounjaro. “With costs rising, individuals are using online platforms. But fake injections are highly dangerous. You cannot know what’s inside or whether the conditions they were produced in was clean,” she explained. Her team has previously seen patients injured by personal administration from unconfirmed sources. “We understand the disappointment, but buying from Telegram or WhatsApp is taking chances with your health,” said the doctor. “These substances could be contaminated or incorrectly dosed.” Producer Position A spokesperson from Eli Lilly said the substance was in third stage clinical trials and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Consequently at this time no one can market [it] for personal consumption,” they said, adding that any item “falsely representing itself as a company experimental substance not yet approved … may expose users to possibly serious health risks”.